895|10000|Public
25|$|Neuroglia ("glial cells") {{may play}} a role in central sensitization. <b>Peripheral</b> <b>nerve</b> <b>injury</b> induces glia to release proinflammatory cytokines and glutamate—which, in turn {{influence}} neurons.|$|E
25|$|Investigators {{estimate}} that 2-5% {{of those with}} <b>peripheral</b> <b>nerve</b> <b>injury,</b> and 13-70 percent of those with hemiplegia (paralysis of {{one side of the}} body), will develop CRPS. In addition, some studies have indicated that cigarette smoking was strikingly present in patients and is statistically linked to RSD. This may be involved in its pathology by enhancing sympathetic activity, vasoconstriction, or by some other unknown neurotransmitter-related mechanism. This hypothesis was based on a retrospective analysis of 53 patients with RSD, which showed that 68% of patients and only 37% of controls were smokers. The results are preliminary and are limited by their retrospective nature. 7% of people who have CRPS in one limb later develop it in another limb.|$|E
2500|$|Under normal conditions, pain {{conduction}} {{begins with}} some noxious signal {{followed by an}} action potential carried by nociceptive (pain sensing) afferent neurons, which elicit excitatory postsynaptic potentials (EPSP) in the dorsal horn of the spinal cord. That message is then relayed to the cerebral cortex, where we translate those EPSPs into [...] "pain." [...] Since the discovery of astrocytic influence, {{our understanding of the}} conduction of pain has been dramatically complicated. Pain processing is no longer seen as a repetitive relay of signals from body to brain, but as a complex system that can be up- and down-regulated by a number of different factors. One factor at the forefront of recent research is in the pain-potentiating synapse located in the dorsal horn of the spinal cord and the role of astrocytes in encapsulating these synapses. Garrison and co-workers were the first to suggest association when they found a correlation between astrocyte hypertrophy in the dorsal horn of the spinal cord and hypersensitivity to pain after <b>peripheral</b> <b>nerve</b> <b>injury,</b> typically considered an indicator of glial activation after injury.|$|E
40|$|With {{advances}} in biomedical methods, tissue-engineered materials have developed rapidly {{as an alternative}} to nerve autografts for the repair of <b>peripheral</b> <b>nerve</b> <b>injuries.</b> However, the materials selected for use in the repair of <b>peripheral</b> <b>nerve</b> <b>injuries,</b> in particular multiple injuries and large-gap defects, must be chosen carefully. Various methods and materials for protecting the healthy tissue and repairing <b>peripheral</b> <b>nerve</b> <b>injuries</b> have been described, and each method or material has advantages and disadvantages. Recently, a large amount of research has been focused on tissue-engineered materials for the repair of <b>peripheral</b> <b>nerve</b> <b>injuries.</b> Using the keywords "pe-ripheral nerve injury", "autotransplant", "nerve graft", and "biomaterial", we retrieved publications using tissue-engineered materials for the repair of <b>peripheral</b> <b>nerve</b> <b>injuries</b> appearing in the Web of Science from 2010 to 2014. The country with the most total publications was the USA. The institutions that were the most productive in this field include Hannover Medical School (Germany), Washington University (USA), and Nantong University (China). The total number of publications using tissue-engineered materials for the repair of <b>peripheral</b> <b>nerve</b> <b>injuries</b> grad-ually increased over time, as did the number of Chinese publications, suggesting that China has made many scientific contributions to this field of research...|$|R
40|$|Patients with <b>peripheral</b> <b>nerve</b> <b>injuries,</b> {{especially}} severe injury, often face poor {{nerve regeneration}} and incomplete functional recovery, even after surgical nerve repair. This review summarizes treatment options of <b>peripheral</b> <b>nerve</b> <b>injuries</b> with current techniques and concepts and reviews developments {{in research and}} clinical application of these therapies...|$|R
5000|$|PMF 5053 (1947) - Therapeutic Exercise, <b>Peripheral</b> <b>Nerve</b> <b>Injuries</b> (16 min).|$|R
50|$|It is the mildest type of <b>peripheral</b> <b>nerve</b> <b>injury.</b>|$|E
5000|$|In 1943, Seddon {{described}} {{three basic}} types of <b>peripheral</b> <b>nerve</b> <b>injury</b> [...] that include: ...|$|E
5000|$|St Bartholomew's Hospital, Senior House Surgeon, Chief Assistant to the Orthopaedic Unit, Registrar of the <b>Peripheral</b> <b>Nerve</b> <b>Injury</b> Unit (1934-1946) ...|$|E
40|$|Introducti 0 n. <b>Peripheral</b> <b>nerve</b> <b>injuries</b> {{are one of}} {{the common}} traumas in various sport fields. Nowadays, thera are a growing {{tendency}} to Martial arts among young people. Insufficient knowlodage about the biomechanics and true skills in these sports can expose the athletes to many neuromusculoskeletal <b>injuries</b> including <b>peripheral</b> <b>nerve</b> <b>injuries.</b> The aim of this study was assessment of <b>peripheral</b> <b>nerve</b> <b>injuries</b> among Kick-boxers. &# 13; Methods. The research was done on 30 male kick-boxers Aged between 17 - 28 years. Ulnar, tibial and median nerves were studied for the presence of unlar nerve entrapment on elbow, trasal tunnel syndrom and carpal tunnel syndrom. &# 13; Results. Ulnar neuropathy was observed in 12 cases. Tibial entrapment was detected in 13 cases. No median nerve intrapment of CTS was detected. There was a significant correlation between the age of the participants and nerve entrapment. &# 13; Discussion. <b>Peripheral</b> <b>nerve</b> <b>injuries</b> should be considered in athletes and should be trained to apply preventive and thrapeutic procedures...|$|R
40|$|After <b>peripheral</b> <b>nerve</b> <b>injuries</b> {{patients}} {{lose and}} do not recover the stretch reflex which leads to altered locomotor function. The focus of this thesis is to investigate the structural integrity of the central connection between Ia afferents and alpha motoneurons that mediate the stretch reflex. The overall hypothesis is that the density and distribution of Ia synapses on motoneurons is altered after <b>peripheral</b> <b>nerve</b> <b>injuries.</b> Analysis of Ia afferent-motoneuron contacts, revealed by vesicular glutamate transporter 1 (VGLUT 1) immunoreactivity, on the soma and dendritic arbor of motoneurons after <b>peripheral</b> <b>nerve</b> <b>injuries</b> revealed major reorganizations in the distribution and density of Ia synapses. Synaptic stripping of Ia afferent synapses occurred on the soma and proximal dendrites {{and appeared to be}} permanent even after reinnervation; in contrast, VGLUT 1 synapses on distal dendrites were unchanged. In conclusion, after <b>peripheral</b> <b>nerve</b> <b>injuries</b> motoneurons are contacted by fewer Ia synapses and they are more distally located. This overall reorganization likely weakens the input and may contribute to stretch reflex anomalies...|$|R
40|$|Objective. The {{present study}} {{examines}} {{the value of}} intraoperative neurovisualization as an imaging tool for decision making {{in the management of}} traumatic <b>nerve</b> <b>injuries.</b> Materials and methods. 43 patients with traumatic nerve lesions were examined by electrodiagnostic study, ultrasonography and contrast neurography. Results. A complex intraoperative examination have been used to guide surgical decision making in patients with <b>peripheral</b> <b>nerve</b> <b>injuries</b> of limbs. Conclusion. The results of complex intraoperative examination became the basis of diagnosis and treatment algorithm for surgical treatment of <b>peripheral</b> <b>nerves</b> <b>injuries...</b>|$|R
5000|$|McLachlan, E.M., Jänig, W., Devor, M. and Michaelis, M. (1993) <b>Peripheral</b> <b>nerve</b> <b>injury</b> {{triggers}} noradrenergic sprouting within {{dorsal root}} ganglia. Nature, Lond. 363, 543-546 ...|$|E
50|$|Neuroglia ("glial cells") {{may play}} a role in central sensitization. <b>Peripheral</b> <b>nerve</b> <b>injury</b> induces glia to release proinflammatory cytokines and glutamate—which, in turn {{influence}} neurons.|$|E
50|$|Neurapraxia {{results in}} {{temporary}} {{damage to the}} myelin sheath but leaves the nerve intact and is an impermanent condition; thus, Wallerian degeneration does not occur in neurapraxia. In order for the condition to be considered neurapraxia, according to the Seddon classification system of <b>peripheral</b> <b>nerve</b> <b>injury,</b> {{there must be a}} complete and relatively rapid recovery of motor and sensory function once nerve conduction has been restored; otherwise, the injury would be classified as axonotmesis or neurotmesis. Thus, neurapraxia is the mildest classification of <b>peripheral</b> <b>nerve</b> <b>injury.</b>|$|E
5000|$|Median <b>nerve</b> <b>injuries</b> {{were the}} least likely to be {{admitted}} to the emergency room out of all <b>peripheral</b> <b>nerve</b> <b>injuries</b> (median <b>nerve</b> 68.89%, ulnar nerve 71.3% and radial nerve 77.06%).|$|R
2500|$|Sema 3A (Semaphorin 3A) {{is present}} in the scar that forms in both central nervous system [...] and <b>peripheral</b> <b>nerve</b> <b>injuries</b> [...] and {{contributes}} to the outgrowth-inhibitory properties of these scars ...|$|R
40|$|<b>Peripheral</b> <b>nerve</b> <b>injuries</b> that induce gaps {{larger than}} 1 - 2 cm require {{bridging}} strategies for repair. Autologous nerve grafts {{are still the}} gold standard for such interventions, although alternative treatments, as well as treatments to improve the therapeutic efficacy of autologous nerve grafting are generating increasing interest. Investigations are still mostly experimental, although some clinical studies have been undertaken. In this review, we aim to describe the developments in bridging technology which aim to replace the autograft. A multi-disciplinary approach is of utmost importance to develop and optimise treatments of the most challenging <b>peripheral</b> <b>nerve</b> <b>injuries...</b>|$|R
50|$|Following <b>peripheral</b> <b>nerve</b> <b>injury</b> to the ulnar nerve, the AIN {{is often}} used as a donor branch to reinnervate the paralysed muscles innervated by the ulnar nerve.|$|E
50|$|Cytokines {{also play}} a role in {{anti-inflammatory}} pathways and are a possible therapeutic treatment for pathological pain from inflammation or <b>peripheral</b> <b>nerve</b> <b>injury.</b> There are both pro-inflammatory and anti-inflammatory cytokines that regulate this pathway.|$|E
5000|$|PMF 5061 (1947) - Peripheral Nerve Surgery — Part I: Sciatic Nerve; Management {{of typical}} <b>peripheral</b> <b>nerve</b> <b>injury</b> case of WW II; {{follow-up}} treatment at neurosurgical {{centers of the}} Veterans Administration (33 min; color).|$|E
40|$|This study {{investigated}} pre- and post-operative evaluation of <b>peripheral</b> <b>nerve</b> <b>injuries</b> and functional outcomes of <b>peripheral</b> <b>nerve</b> regeneration after {{different type of}} injuries and different type of treatments. Neuromas/scar neuritis and brachial plexus injuries are specifically addressed; literature and experimental evidence on the outcomes of vascularized nerve grafts are presented...|$|R
5000|$|Rehabilitation of the Injured Combatant, Vol 2 (1999) - Offers a {{valuable}} reference for physicians and providers {{who care for}} those injured while fighting. Discusses topics ranging from <b>peripheral</b> <b>nerve</b> <b>injuries</b> to vocational rehabilitation and community reintegration of the wounded combatant: 556 p; ill.|$|R
40|$|Background and Objective: Upper limb <b>peripheral</b> <b>nerve</b> <b>injuries</b> due to {{secondary}} changes in cortical maps cause to long lasting or sometimes permanent sensory-motor impairments. Aim {{of this study}} was to determine feasibility and efficacy of constraint-induced movement therapy (CIMT) on upper limb function in patients with <b>peripheral</b> <b>nerve</b> <b>injuries.</b> Subjects and Methods: In a clinical trial, a convenience sample of 7 patients with median and ulnar <b>nerve</b> <b>injuries</b> (5 men, 2 women; mean age: 28 years) were measured. Following screening and signing informed consent, patients received an intensive practice program for 1. 5 hours daily, 5 days per week, during 4 -week period while their healthy hand was immobilized using a volar wrist and forearm splint during waking hours. Outcome measures including Semmes Weinstein Monofilaments (SWM), Nine-hole Peg Test (9 -HPT), and Motor Activity Log (MAL) questionnaire were administered pre, and post, and 4 weeks after the treatment period. Results: Data analysis did not show any changes in touch perception at tip of the fingers in SWM at post-test session; however, affected hand motor performance in 9 -HPT and affected hand’s amount of use in activities of daily living according to MAL were significantly improved at the post-test session (P 0. 05). Conclusion: CIMT can be considered as an appropriate technique in rehabilitation program for patients with <b>peripheral</b> <b>nerve</b> <b>injuries...</b>|$|R
50|$|Calbindin is {{expressed}} by cerebellar Purkinje cells and granule cells of hippocampus. The reorganization and migration of calbindin-stained Purkinje neurons in rat cerebellum after <b>peripheral</b> <b>nerve</b> <b>injury</b> suggests that calbindin {{may be a}} marker for immature post-mitotic neurons, similar to calretinin.|$|E
50|$|<b>Peripheral</b> <b>nerve</b> <b>injury</b> of the {{sciatic nerve}} (a neuropathic pain model) induces a {{transient}} loss of GAD65 immunoreactive terminals in {{the spinal cord}} dorsal horn and suggests a potential involvement for these alterations {{in the development and}} amelioration of pain behaviour.|$|E
5000|$|In microglia, P2X7 receptors {{are found}} {{mostly on the}} cell surface. Conserved {{cysteine}} residues located in the carboxyl terminus seem to be important for receptor trafficking to the cell membrane. [...] These receptors are upregulated in response to <b>peripheral</b> <b>nerve</b> <b>injury.</b>|$|E
40|$|<b>Peripheral</b> <b>Nerve</b> <b>Injuries</b> {{are one of}} {{the most}} common causes of hand {{dysfunction}} caused by upper limb trauma but still current management has remained suboptimal. This review aims to explain the traditional view of pathophysiology of nerve repair and also describe why surgical management is still inadequate in using the new biological research that has documented the changes that occur after the <b>nerve</b> <b>injury,</b> which, could cause suboptimal clinical outcomes. Subsequently presentation and diagnosis will be described for <b>peripheral</b> <b>nerve</b> <b>injuries.</b> When traditional surgical repair using end-to-end anastomosis is not adequate nerve conduits are required with the gold standard being the autologous nerve. Due to associated donor site morbidity and poor functional outcome documented with autologous nerve repair several new advancements for alternatives to bridge the gap are being investigated. We will summarise the new and future advancements of non-biological and biological replacements as well as gene therapy, which are being considered as the alternatives for <b>peripheral</b> <b>nerve</b> repair...|$|R
50|$|Clinicians and {{researchers}} {{work together to}} treat and to find {{the root causes of}} Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, and <b>peripheral</b> <b>nerve</b> <b>injuries.</b> The Medical Center also is home to an NIH Alzheimer’s Disease Center and is a Network of Excellence in Neuroscience Clinical Trials Center.|$|R
5000|$|The {{endoneurium}} {{contains a}} liquid known as endoneurial fluid, which contains little protein. In the {{peripheral nervous system}} the endoneurial fluid is notionally equivalent to cerebro-spinal fluid in the central nervous system. <b>Peripheral</b> <b>nerve</b> <b>injuries</b> commonly release increased amounts of endoneurial fluid into surrounding tissues; these can be detected by magnetic resonance neurography, thereby assisting in locating <b>injuries</b> to <b>peripheral</b> <b>nerves.</b>|$|R
50|$|It {{has been}} {{postulated}} that the synkinesis {{is due to}} damage to cranial nerve nuclei, caused by <b>peripheral</b> <b>nerve</b> <b>injury</b> and the nuclear lesion releases evolutionarily older neural mechanisms with their tendency toward associated movements, and so primitive reflexes are not inhibited.|$|E
50|$|The {{incidence}} {{of damage to}} the inferior gluteal nerve after replacement of the hip is still uncertain. <b>Peripheral</b> <b>nerve</b> <b>injury</b> may occur during operations on the hip {{as a result of}} operative trauma associated with stretching and retraction of the nerve. Few studies have focused on damage to the inferior gluteal nerve during hip replacement.|$|E
50|$|Erythropoietin and its {{receptor}} {{are also}} {{reported in the}} peripheral nervous system, specifically in the bodies and axons of ganglions in the dorsal root, and at increased levels in Schwann cells after <b>peripheral</b> <b>nerve</b> <b>injury.</b> The distribution of EpoR was different from Epo, specifically in some neuronal cell bodies in the dorsal root ganglion, endothelial cells, and Schwann cells of normal nerves. Most importantly, experiments with immunostaining revealed that the distribution and concentration of EpoR on Schwann cells doesn’t change after <b>peripheral</b> <b>nerve</b> <b>injury.</b> However those studies are of questionable significance since the antibodies were nonspecific to EpoR. Otherr research that suggested Epo is up-regulated according to mRNA expression in astrocytes and hypoxia-induced neurons, while EpoR is not. A correlation between the expression of Epo-R in ganglion cells and binding to sensory receptors in the periphery like Pacini bodies and neuromuscular spindles suggests that Epo-R is related to touch regulation.|$|E
40|$|Thirty-one {{examples}} of iatrogenic <b>peripheral</b> <b>nerve</b> <b>injuries</b> {{have been collected}} from {{a review of the}} case records of one neurological referral centre over a 7 -year period. The clinical details are described {{to call attention to the}} special care needed with the management of patients subjected to certain invasive procedures...|$|R
50|$|AxoGen {{is a human}} tissue {{company based}} in Alachua, Florida making {{products}} to remedy <b>peripheral</b> <b>nerve</b> damage. In 2013 the company raised $18 million in its Initial Public Offering (IPO). AxoGen uses a cell graft technology AVANCE to mimic a human nerve. The company reports recovery in 87 percent of patients with <b>peripheral</b> <b>nerve</b> <b>injuries.</b> AxoGen {{is part of the}} Sid Martin Biotechnology Incubator.|$|R
40|$|Introduction: Transplantation of {{bone marrow}} stromal cells (BMSCs) or Schwann cells (SCs) can {{increase}} axonal regeneration in <b>peripheral</b> <b>nerve</b> <b>injuries.</b> Based on our previous investigations, {{the goal of}} the present work was to examine the individual and synergistic effects of the two different cell types in sciatic <b>nerve</b> <b>injury.</b> We pursued to evaluate the effects of BMSCs and SCs co-transplantation on the functional recovery after sciatic nerv...|$|R
